Proliferative lesions induced by 2,6-dimethylanilin e (DMA) in a two-stage rat nasal carcinogenesi s model were immunohistochemicall y and ultrastructurally investigated. Male F344 rats received diet containing 3,000 ppm DMA for 52 weeks after initiation with a single subcutaneous injection of 2400 mg/kg of N -bis(2-hydroxypropyl)nitrosamine (DHPN). Histopathologically, proliferation of Bowman's glands, glandular hyperplasias, dysplastic foci, adenomas, and carcinomas were observed in treated rats. These nasal lesions mostly arose in the olfactory mucosa of the nasal cavity. Immunohistochemically , they were positive for cytokeratin and/or collagen type IV antibodies. Ultrastructurally, intracytoplasmi c dense secretory granules (200-850 nm in diameter), identical to those in normal Bowman's glands, were observed in all the lesions, providing further support from an origin from these glands. Based on their cellular characterization, growth pattern and/or proliferative activity, two morphological continua were evident, one from dysplastic foci to carcinomas and the other from proliferation of Bowman's glands to glandular hyperplasias and adenomas. These results suggest that dysplastic foci arise from Bowman's glands and progress to carcinomas, while proliferation of Bowman's glands result in glandular hyperplasias and adenomas.
INTRODUCTION 2,6-Dimethylaniline (DMA) has been shown to cause a signi cant increase in the incidence of nasal tumors including adenomas, adenocarcinomas, and carcinomas in both male and female rats fed diet containing 3,000 ppm DMA for 2 years (26) . In addition, DMA proved mutagenic in mouse lymphoma cells and tests for sister chromatid exchange and chromosomal aberrations, although not positive in Ames tests (12, 13, 28, 35) . DMA is one of the major metabolites of xylazine (XZ), an a 2 -adrenergic agonist with sedative, muscle relaxant, and analgesic properties that is commonly used in animals, including cattle, horses, sheep, goats, swine, dogs, and cats (33, 34) . There is some concern about carcinogenic effects of DMA on consumers via ingestion of edible tissues in food-producing animals treated with XZ.
In our previous two-stage nasal carcinogenesis study of DMA in rats using N -bis(2-hydroxypropyl)nitrosamine (DHPN) as an initiator, development of epithelial hyperplasias, dysplastic foci, and epithelial tumors in the nasal cavity was clearly enhanced by dietary administration of DMA at the dose of 3,000 ppm for 52 weeks (19) . Carcinomas were observed at high incidence and histologically resembled those found in the 2-year carcinogenicity study of DMA in rats, and the observed morphological continuum between dysplastic foci and carcinomas indicated a histological relationship (19) . The results of our previous study strongly suggested that DHPN acts as an initiator of nasal carcinogenesis whereas DMA exerts tumor promoting effects on the olfactory mucosa. On the other hand, XZ did not enhance lesion development in the nasal tissues after initiation with DHPN (20) . In our previous sequential study of DMA effects in the rat two-stage nasal carcinogenesis model using DHPN, atrophy of Bowman's glands was observed as an early toxic lesion in the olfactory mucosa (18) . Electron microscopically, tumor cells of carcinomas in that study were demonstrated to have desmosomes, intracytoplasmic dense secretory granules 300 0192-6233/01$3.00 $0.00 identical to those in normal Bowman's glands, a basement membrane, and microvilli (18) . These results suggested that Bowman's glands are the target of DMA, giving rise to nasal carcinomas after DHPN-initiation (18) . However, it has hitherto remained unclear whether all induced-tumors are derived from Bowman's glands. Nasal tumors arising from the olfactory mucosa in rodents have been classi ed as neuroepithelial carcinomas, Bowman's gland carcinomas, adenosquamous carcinomas, squamous cell carcinomas, and epidermoid (inverted) papillomas (7, 24) . These tumors are considered to originate from olfactory epithelial elements (sensory cells, sustentacular cells, basal cells, or cells lining the duct of Bowman's gland) and the elements of the lamina propria (24). Bowman's gland tumors are frequently induced by chemicals damaging the olfactory mucosa developing within a background of diffuse hyperplasia, hypertrophy, atypia, and necrosis of Bowman's glands (7, 8) . In addition, hyperplasias of Bowman's glands with cytoplasmic basophilia and large hyperchromatic atypical nuclei are always associated with neoplastic transformation (7).
The current study, consisting of immunohistochemical and electron microscopic analyses, was performed to clarify the morphogenesis of nasal proliferative lesions in rats induced by DMA after DHPN initiation, using histological samples obtained in our previous study (19) . The morphogenesis of these lesions was analysed by the comparison of histopathological differences and/or similarities in each proliferative lesion to clarify whether all-induced tumors are derived from Bowman's glands.
MATERIALS AND METHODS
All histological samples examined in this study were from a previous study described in detail elsewhere (19) . Brie y, a total of 50 male F344 rats were obtained from Charles River Japan Inc, Kanagawa, Japan, at 4 weeks of age, and they were randomly subdivided into a DHPN DMA group (N 30) and a DHPN alone group (N 20) . DMA (purity, > 99%) and DHPN were obtained from Wako Pure Chemical Industries, Ltd., (Osaka, Japan) and Nacalai Tesque, Inc, (Kyoto, Japan), respectively. The animals were given a single subcutaneous injection of 2,400 mg/kg of DHPN in isotonic sodium chloride solution. Starting 1 week after this initiation treatment, the animals in the DHPN DMA and DHPN alone groups were given pulverized diet containing 3,000 ppm DMA and the pulverized basal diet, respectively, for 52 weeks. All animals were handled in accordance with the Guideline for Animal Experimentation of the Japanese Association for Laboratory Animal Science. All surviving animals were killed under ether anesthesia by exsanguination from the abdominal aorta at week 52, and subjected to a complete necropsy. Nasal cavities were xed with 10% neutral buffered formalin after ushing the xative into the posterior opening of the nasopharynx with a syringe. Following xation, the heads were decalci ed in 5% formic acid solution. Using the upper incisor teeth, incisive papilla, and rst upper molar tooth as guides for trimming, 6 transverse sections including Levels I, II, and III of the nasal cavity were prepared based on the method of Nagano et al. (25) . After post xation, the nasal sections were embed- ded in paraf n and sectioned at 4-5 l m. In addition, right nasal turbinates sampled from 5 rats in the DHPN DMA group, and some adenomas and carcinomas observed in the DHPN DMA group were xed with modi ed methacarn xative (22) , embedded in paraf n without decalci cation, and sectioned at 4-5 l m. These sections were stained with hematoxylin and eosin (H&E) or periodic acid-Schiff (PAS) for light microscopic examination. Proliferative nasal lesions were distinguished according to the criteria using in our previous studies (18, 19) . Proliferation of Bowman's glands was characterized by increased numbers of Bowman's gland consisting of cuboidal cells of single layer in the lamina propria. Glandular hyperplasias were composed of small nests of glandular structures consisting of strati ed cuboidal cells of single layer, in which their origin could not be identi ed, frequently accompanied by in ammation. Dysplastic foci were small atypical solid nests of cuboidal to pleomorphic cells with hyperchromatic nuclei and basophilic cytoplasm in the lamina propria. Adenomas showed glandular and/or papillary growth pattern of well-differentiated cuboidal tumor cells with glandular structures. Carcinomas were characterized by expansive solid and/or glandular growth of pleomorphic tumor cells with basophilic cytoplasm and bizarre and/or hyperchromatic nuclei.
Additional sections were stained immunohistochemically with mouse monoclonal anti-rat proliferative cell nuclear antigen (PCNA; diluted 1/100) (DAKO A/S, Glostrup, Denmark), mouse monoclonal anti-human cytokeratin (1/100) (DAKO A/S), mouse monoclonal anti-swine vimentin (1/50) (DAKO A/S), mouse monoclonal anti-human neuro lament protein (1/100) (DAKO A/S) and rabbit polyclonal anti-mouse collagen IV (1/100) (CHEMICON International, Inc, CA, USA) antibodies by the streptavidinbiotin-peroxidase complex (streptABComplex/HRP ) method (DAKO A/S). Nasal epithelial cells, broblasts in the lamina propria, nerve bers in the lamina propria and epithelial basement membranes of the nasal epithelium in these sections were used as positive control tissues for cytokeratin, vimentin, neuro lament protein and collagen IV antibodies, respectively. For measurement of PCNA labeling indices, 5 animals in the DHPN DMA group and 3 animals in the DHPN alone group were used. Then, a total of 10 to 16 areas (100 cells/area) in each nasal lesion of each group were randomly selected and were counted under light microscopy. The cells in which only nuclei stained with a substrate chromogen were determined as positive cells for PCNA labeling indices.
A total of 6 tumors consisting of 4 carcinomas and 2 adenomas from moribund, sacri ced, or surviving animals and partial olfactory mucosa from surviving animals in the DHPN DMA group were removed and xed in xative (2.5% gultaraldehyde and 4.0% paraformaldehyde in 0.1 M phosphate buffer) for 2 hours at 4 C, post xed in phosphate-buffered 1.0% osmium tetroxide for 1 hour, dehydrated through a series of alcohols and embedded in Epon 812. Ultrathin sections were contrasted with uranyl acetate and lead citrate, and 3 to 6 grids for each tumor and lesion were examined under electron microscopes (JEM 100CXS, JEOL or H-7000, Hitachi Ltd, Tokyo, Japan). (Table 1) . These nasal lesions were mostly evident in the olfactory mucosa in the nasal cavity. In addition, most Bowman's glands in the olfactory mucosa, except for these exhibiting proliferation, showed atrophic changes in the DHPN DMA group. In severe cases, loss of Bowman's glands was apparent. Proliferation of Bowman's glands was characterized by increased numbers of Bowman's glands, which were composed of single layer of cuboidal cells, with slight luminal dilatation (Figure 1 ). Glandular hyperplasias were characterized by small proliferative foci consisting of strati ed cuboidal cells of single layer, that were morpho- (Figure 2 ). Dysplastic foci were characterized by small solid nests of cuboidal to pleomorphic cells in the lamina propria with basophilic cytoplasm and hyperchromatic nuclei ( Figure 3 ). Adenomas showed glandular and/or papillary growth patterns of cuboidal tumor cells, projecting into the nasal lumen (Figure 4 ). Carcinomas were characterized by solid and/or glandular growth of pleomorphic tumor cells with basophilic cytoplasm and bizarre and/or hyperchromatic nuclei ( Figure 5 ). As evidence of morphological continua, adenomas were composed of cuboidal cells with glandular structures in common with proliferation of Bowman's glands and glandular hyperplasias, and carcinomas composed of pleomorphic cells with basophilic cytoplasm and hyperchromatic nuclei in common with dysplastic foci. Small to large numbers of PAS-positive granules in the cytoplasm were observed in proliferation of Bowman's glands, glandular hyperplasias, dysplastic foci and adenomas, but not in carcinomas.
The results of immunohistochemical staining are summarized in Tables 2 and 3 . The values of PCNA labeling indices of dysplastic foci were signi cantly higher than the values for proliferation of Bowman's glands or glandular hyperplasias, but signi cantly lower than those of carcinomas ( Table 2 ). The cells forming proliferation of Bowman's glands, glandular hyperplasias, dysplastic foci and adenomas were positive for cytokeratin antibody, but carcinomas were negative (Table 3, Figure 6 ). Basal lamina surrounding the glandular hyperplasias, adenomas and carcinomas was positive for collagen type IV antibody, but the tissues in proliferation of Bowman's glands and dysplastic foci were negative in line with their thin basal lamina (Table 3, Figure 7) . None of the nasal proliferative lesions were stained with vimentin or neuro lament protein antibodies (Table 3 ). In contrast, broblasts in the lamina propria were positive for vimentin, and nerve bers in the lamina propria and sensory cells were positive for neuro lament protein. These results suggest that all these lesions arise from epithelial cells including Bowman's glands, rather than from mesenchymal cells or olfactory neuroepithelial (sensory) cells.
Ultrastructurally, the cells composing glandular hyperplasias had glandular structures and large numbers of dense 
DISCUSSION
The pseudostrati ed olfactory epithelium of the nasal cavity in rodents is made up of sustentacular, sensory, and basal cells (1, 14) . The sensory cells are bipolar neurons for which the sustentacular cells have been considered to provide support. The basal cells are generally considered the stem cells for regeneration of epithelium. The lamina propria of the olfactory region contains prominent Bowman's glands, whose ducts traverse the basal lamina, extend through the olfactory epithelium, and open on the luminal surface (1, 14) . In the present study, the nasal proliferative lesions induced by DHPN/DMA treatment were observed mainly in the olfactory region of the nasal cavity. Proliferation of Bowman's glands and glandular hyperplasias were observed in all animals of the DHPN DMA group, and dysplastic foci, adenomas and carcinomas were also observed at high incidences (27-33%). Histopathologically, small to large numbers of PAS-positive granules in cytoplasm were observed in proliferation of Bowman's glands, glandular hyperplasias, dysplastic foci and adenomas. In addition, small to large numbers of dense secretory granules identical to those in normal Bowman's glands were ultrastructurally observed in glandular hyperplasias, dysplastic foci, adenomas and carcinomas. Bowman's glands contain copious amounts of neutral and acidic mucosubstances stained with PAS (10, 14, 32) . Ultrastructurally, these mucosubstances are observed as large secretory granules (32) . Therefore, glandular hyperplasias, dysplastic foci, adenomas, and carcinomas observed in this study were considered to arise from Bowman's glands. It was demonstrated in our previous study that Bowman's glands are the target of DMA toxicity, with atrophy and subsequent regenerative proliferation being evident (18) . In the present study, almost all of the Bowman's glands in the olfactory mucosa, except for these exhibiting proliferation, showed atrophic changes or disappeared from the lamina propria. Glandular hyperplasias had a clear morphological resemblance-the lesion composed of cuboidal cells with glandular structure-to the proliferation of Bowman's glands. Therefore, glandular hyperplasias of the olfactory mucosa was considered to arise from Bowman's glands, presumably as a reactive change following atrophy. Glandular hyperplasias had similarities in values for PCNA labeling and positive results for cytokeratin and collagen type IV antibodies to some adenomas. Bowman's gland tumors appear to arise within a background of diffuse hyperplasia, hypertrophy, atypia and necrosis of Bowman's glands (7, 8) . In addition, it is described that tumors arising in Bowman's glands initially appear as foci of hyperplasia of the ductular and secretory components (24) . The ndings in our study suggest that the glandular hyperplasias can progress to adenomas.
In our study, there was a morphological continuum from dysplastic foci to carcinomas. Their morphological features were marked proliferation of tumor cells with hyperchromatic nuclei and basophilic cytoplasm, clearly different from those in proliferation of Bowman's glands, glandular hyperplasias and adenomas. In addition, no atypical epithelial cell like a dysplastic foci and carcinomas was observed in glandular hyperplasias and adenomas. The value for PCNA labeling indices of dysplastic foci was signi cantly higher than that of glandular hyperplasias or adenomas, and that of carcinomas was signi cantly higher than that of dysplastic foci. These differences of the values for PCNA labeling index indicate that both dysplastic foci and carcinomas possess an extremely high proliferative activity that is totally different from those of glandular hyperplasias and adenomas. These results strongly suggest that dysplastic foci arise from Bowman's glands and can progress directly to carcinomas without any intervening adenoma stage.
A large number of chemicals and xenobiotics have been reported to induce carcinogenic or toxic responses in the nasal cavity (8, 15, 27) . In many cases, toxicity is restricted to speci c areas of the nasal cavity (27) . When xenobiotics reach the nasal mucosa via the air ow or the circulated blood, they may then be subjected to metabolic detoxication or activation (23) . A number of N -nitrosamines are known to be metabolically activated by various cytochrome P-450 (P-450) enzymes and a high metabolic activation or covalent binding of these compounds occur in the nasal mucosa (3, 5, 6, 16) . For example, preferential covalent binding of 14 C-labeled N -nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Bowman's glands of rats given a single intravenous injection of these carcinogens was found by light microscopic autoradiography (9, 21, 31 ). 2,6-Dichlorobenzonitrile (dichlobenil) is known to induce necrosis of Bowman's glands followed by degeneration and desquamation of the olfactory epithelia in mice (2, 4) . Light microscopic autoradiography of mice given a single intravenous injection of 14 C-labeled dichlobenil also demonstrated high irreversible binding in the Bowman's glands (2) . However, olfactory toxic effects of dichlobenil could be prevented by diethyldithiocarbamate inhibition of P-450 2E1 action (11) .
In addition, metyrapone, a non-speci c inhibitor of P-450 enzymes, has been reported to reduce the incidence and severity of RP 73401 [3-(cyclopentyloxy) -N -(3,5-dichloro-4-pyridy)-4-methoxybenzamide], a type IV phosphodiesterase inhibitor, -induced degeneration of olfactory epithelia and Bowman's glands in rats (17) . Sustentacular cells and Bowman's glands in the olfactory mucosa in rats are known to be important sites of xenobiotic metabolism (14) . The results of our previous study suggested that Bowman's glands are the target of DMA (18) , which has been reported to covalently bind to DNA of the ethmoid turbinate epithelium of rats given a single intraperitoneal injection of 14 C-labeled compound after pre-treatment with 262.5 mg/kg/day unlabeled DMA for 9 days (30) . Taking into account these ndings, the toxic and carcinogenic effects of DMA in the Bowman's glands of the rat nasal cavity can be concluded to depend on the tissue speci c metabolism of enzymes such as P-450 enzymes and binding of metabolites.
Based on the results of immunohistochemistry and electron microscopy in the present study, the following scheme can be considered as a possible pathogenesis of nasal tumors in rats induced by DMA after initiation with DHPN ( Figure 11 ): (a) initiated cells occur in epithelial cells of Bowman's glands due to DNA damage with DHPN initiation; (b) atrophy of Bowman's glands and subsequent compensatory regeneration of Bowman's glands are induced as a toxic effect of repeated DMA exposure; (c) such a regeneration results in dysplastic foci grown from initiated cells or proliferation of Bowman's glands under the promoting effects of DMA; (d) adenomas arise from proliferation of Bowman's glands via glandular hyperplasias under the promoting effects of DMA; (e) dysplastic foci directly progress to carcinomas under the promoting effects of DMA. Regarding the morphogenesis of adenomas, there may be another pathway that adenomas arise from initiated sustentacular and other epithelial cells of the olfactory and respiratory epithelia, because of their morphological resemblance and the report describing that nasal tumors in rats induced by nitrosamines may be derived from respiratory and olfactory epithelia (29).
In conclusion, our results strongly suggest that cells initiated by DHPN in the epithelium of Bowman's glands are responsible for the genesis of dysplastic foci/carcinomas and adenomas, by separate pathways, on repeated treatment with DMA.
